• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核磷酸肌醇在p53-MDM2关系中的作用。

The Role of Nuclear Phosphoinositides in the p53-MDM2 Nexus.

作者信息

Lee Jeong Hyo, Salah Muhammad Khalil, Chen Xiangqin, Kucherenko Nickolas Vladimir, Cryns Vincent L, Anderson Richard A

机构信息

University of Wisconsin Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.

Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.

出版信息

Cells. 2025 Jul 22;14(15):1126. doi: 10.3390/cells14151126.

DOI:10.3390/cells14151126
PMID:40801560
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12346208/
Abstract

Recent insights into the p53-MDM2 nexus have advanced deeper understanding of their regulation and potent impact on cancer heterogeneity. The roles of nuclear phosphoinositide (PIPs) in modulating this pathway are emerging as a key mechanism. Here, we dissect the molecular mechanisms by which nuclear PIPs stabilize p53 through the recruitment of small heat shock proteins (sHSPs), activate the nuclear phosphatidylinositol 3-kinase (PI3K)-AKT signaling cascade, and modulate MDM2 function to regulate the p53-MDM2 interaction. We propose potential mechanisms by which nuclear PIPs coordinate signaling with nuclear p53, AKT, and MDM2. Ultimately, we highlight that nuclear PIPs serve as a 'third messenger' within the p53-MDM2 axis, expanding the current framework of non-canonical nuclear signaling in cancer biology.

摘要

最近对p53-MDM2关系的深入了解,加深了人们对其调控以及对癌症异质性的强大影响的认识。核磷酸肌醇(PIPs)在调节这一信号通路中的作用正逐渐成为一种关键机制。在这里,我们剖析了核PIPs通过招募小热休克蛋白(sHSPs)来稳定p53、激活核磷脂酰肌醇3激酶(PI3K)-AKT信号级联反应以及调节MDM2功能以调控p53-MDM2相互作用的分子机制。我们提出了核PIPs与核p53、AKT和MDM2协调信号传导的潜在机制。最终,我们强调核PIPs在p53-MDM2轴中作为“第三信使”,扩展了癌症生物学中非经典核信号传导的当前框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f79d/12346208/2d874c78df67/cells-14-01126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f79d/12346208/12d7bc11f927/cells-14-01126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f79d/12346208/2d874c78df67/cells-14-01126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f79d/12346208/12d7bc11f927/cells-14-01126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f79d/12346208/2d874c78df67/cells-14-01126-g002.jpg

相似文献

1
The Role of Nuclear Phosphoinositides in the p53-MDM2 Nexus.核磷酸肌醇在p53-MDM2关系中的作用。
Cells. 2025 Jul 22;14(15):1126. doi: 10.3390/cells14151126.
2
EVA1A reverses lenvatinib resistance in hepatocellular carcinoma through regulating PI3K/AKT/p53 signaling axis.EVA1A 通过调节 PI3K/AKT/p53 信号轴逆转肝癌对乐伐替尼的耐药性。
Apoptosis. 2024 Aug;29(7-8):1161-1184. doi: 10.1007/s10495-024-01967-0. Epub 2024 May 14.
3
Regulation of the MDM2-p53 Nexus by a Nuclear Phosphoinositide and Small Heat Shock Protein Complex.一种核磷酸肌醇与小分子热休克蛋白复合物对MDM2-p53关系的调控
J Biol Chem. 2025 Jul 26:110527. doi: 10.1016/j.jbc.2025.110527.
4
Regulation of the MDM2-p53 Nexus by a Nuclear Phosphoinositide and Small Heat Shock Protein Complex.一种核磷酸肌醇与小分子热休克蛋白复合物对MDM2-p53关系的调控
bioRxiv. 2025 Apr 17:2025.04.11.648454. doi: 10.1101/2025.04.11.648454.
5
USP38 functions as an oncoprotein by downregulating the p53 pathway through deubiquitination and stabilization of MDM2.USP38通过去泛素化和稳定MDM2来下调p53途径,从而发挥癌蛋白的作用。
Cell Death Differ. 2025 Feb 22. doi: 10.1038/s41418-025-01462-2.
6
A structure-based virtual screening identifies a novel MDM2 antagonist in the activation of the p53 signaling and inhibition of tumor growth.基于结构的虚拟筛选鉴定出一种新型MDM2拮抗剂,可激活p53信号通路并抑制肿瘤生长。
Acta Pharmacol Sin. 2025 Mar;46(3):740-750. doi: 10.1038/s41401-024-01394-6. Epub 2024 Oct 9.
7
Pracinostat inhibits the nefarious biological behavior of pancreatic cancer by targeting the miR-381-3p/MDM2 axis to activate the p53 signaling pathway.普拉西诺司他通过靶向miR-381-3p/MDM2轴激活p53信号通路,抑制胰腺癌的恶性生物学行为。
Pathol Res Pract. 2025 Oct;274:156186. doi: 10.1016/j.prp.2025.156186. Epub 2025 Aug 25.
8
Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.暴露于铂类DNA损伤剂的敏感和耐药人类癌症模型中p53磷酸化状态及功能
J Cancer Res Clin Oncol. 2003 Dec;129(12):709-18. doi: 10.1007/s00432-003-0480-4. Epub 2003 Sep 26.
9
HPV16 E6 and Chlamydia trachomatis Pgp3 proteins inhibit TNF-α-induced apoptosis through Daxx-mediated MDM2-p53 pathway.人乳头瘤病毒16型E6蛋白和沙眼衣原体Pgp3蛋白通过Daxx介导的MDM2-p53途径抑制肿瘤坏死因子-α诱导的细胞凋亡。
Microb Pathog. 2025 Sep;206:107849. doi: 10.1016/j.micpath.2025.107849. Epub 2025 Jun 28.
10
The poly(A) polymerase Star-PAP is regulated by stably associated phosphoinositide messengers.聚腺苷酸聚合酶Star-PAP受稳定结合的磷酸肌醇信使调控。
J Biol Chem. 2025 Jun 24;301(8):110412. doi: 10.1016/j.jbc.2025.110412.

本文引用的文献

1
Regulation of the MDM2-p53 Nexus by a Nuclear Phosphoinositide and Small Heat Shock Protein Complex.一种核磷酸肌醇与小分子热休克蛋白复合物对MDM2-p53关系的调控
J Biol Chem. 2025 Jul 26:110527. doi: 10.1016/j.jbc.2025.110527.
2
The poly(A) polymerase Star-PAP is regulated by stably associated phosphoinositide messengers.聚腺苷酸聚合酶Star-PAP受稳定结合的磷酸肌醇信使调控。
J Biol Chem. 2025 Jun 24;301(8):110412. doi: 10.1016/j.jbc.2025.110412.
3
Regulation of NRF2 by stably associated phosphoinositides and small heat shock proteins in response to stress.
应激反应中稳定相关的磷酸肌醇和小分子热休克蛋白对NRF2的调控
J Biol Chem. 2025 Jun 12;301(7):110367. doi: 10.1016/j.jbc.2025.110367.
4
Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer.核磷酯酰肌醇信号促进乳腺癌中 YAP/TAZ-TEAD 转录活性。
EMBO J. 2024 May;43(9):1740-1769. doi: 10.1038/s44318-024-00085-6. Epub 2024 Apr 2.
5
PDK1 promotes breast cancer progression by enhancing the stability and transcriptional activity of HIF-1α.丙酮酸脱氢酶激酶1(PDK1)通过增强缺氧诱导因子-1α(HIF-1α)的稳定性和转录活性来促进乳腺癌进展。
Genes Dis. 2023 Jul 15;11(4):101041. doi: 10.1016/j.gendis.2023.06.013. eCollection 2024 Jul.
6
Targeting p53 pathways: mechanisms, structures, and advances in therapy.靶向 p53 通路:机制、结构和治疗进展。
Signal Transduct Target Ther. 2023 Mar 1;8(1):92. doi: 10.1038/s41392-023-01347-1.
7
Mutant p53 in cancer: from molecular mechanism to therapeutic modulation.癌症中的突变型 p53:从分子机制到治疗调节。
Cell Death Dis. 2022 Nov 18;13(11):974. doi: 10.1038/s41419-022-05408-1.
8
Interactions between mTORC2 core subunits Rictor and mSin1 dictate selective and context-dependent phosphorylation of substrate kinases SGK1 and Akt.mTORC2 核心亚基 Rictor 和 mSin1 之间的相互作用决定了底物激酶 SGK1 和 Akt 的选择性和上下文相关的磷酸化。
J Biol Chem. 2022 Sep;298(9):102288. doi: 10.1016/j.jbc.2022.102288. Epub 2022 Aug 1.
9
A p53-phosphoinositide signalosome regulates nuclear AKT activation.p53 磷酸肌醇信号体调节核 AKT 的激活。
Nat Cell Biol. 2022 Jul;24(7):1099-1113. doi: 10.1038/s41556-022-00949-1. Epub 2022 Jul 7.
10
Targeting PI3K/Akt signal transduction for cancer therapy.针对 PI3K/Akt 信号转导通路的癌症治疗策略。
Signal Transduct Target Ther. 2021 Dec 16;6(1):425. doi: 10.1038/s41392-021-00828-5.